Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol cardioprotection in valve surgery
PACTR201907764652028Phase 4Completed
- Sponsor
- Tanta University Hospitals
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propofol in rheumatic heart disease (RHD) (3 arms), sponsored by Tanta University Hospitals. Primary endpoint: Cardiac troponin T level. Started Nov 2018; status: completed.
02
Drugs
propofol
03
Conditions
rheumatic heart disease (RHD)
Beyond the preview
Go deeper on PACTR201907764652028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201907764652028.